Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:16 pm Sale |
2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,314,915 2.820% |
-457,800![]() (-25.82%) |
Filing History |
2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Schonfeld Strategic Advisors LLC | 8,769,640 7.540% |
8,769,640![]() (New Position) |
Filing History |
2025-02-14 4:15 pm Purchase |
2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN |
Schonfeld Strategic Advisors LLC | 5,234,508 6.160% |
5,234,508![]() (New Position) |
Filing History |
2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Schonfeld Strategic Advisors LLC | 1,772,715 5.300% |
1,772,715![]() (New Position) |
Filing History |
2024-02-14 4:31 pm Sale |
2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Schonfeld Strategic Advisors LLC | 1,900 0.180% |
-49,460![]() (-96.30%) |
Filing History |
2024-02-14 4:30 pm Sale |
2023-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 41,993 0.100% |
-3,546,723![]() (-98.83%) |
Filing History |
2023-02-14 4:32 pm Sale |
2022-12-31 | 13G | MarketWise, Inc. MKTW |
Schonfeld Strategic Advisors LLC | 0 0.000% |
-1,468,900![]() (Position Closed) |
Filing History |
2023-02-14 4:31 pm Purchase |
2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Schonfeld Strategic Advisors LLC | 51,360 6.140% |
51,360![]() (New Position) |
Filing History |
2023-02-14 4:30 pm Sale |
2022-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 3,588,716 7.990% |
-1,121,757![]() (-23.81%) |
Filing History |
2022-06-09 4:45 pm Purchase |
2022-05-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 4,710,473 10.500% |
2,086,113![]() (+79.49%) |
Filing History |
2022-02-15 4:07 pm Purchase |
2021-12-31 | 13G | MarketWise, Inc. MKTW |
Schonfeld Strategic Advisors LLC | 1,468,900 5.840% |
1,468,900![]() (New Position) |
Filing History |
2022-02-14 11:36 am Purchase |
2021-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
Schonfeld Strategic Advisors LLC | 2,624,360 6.000% |
2,624,360![]() (New Position) |
Filing History |
2022-02-14 11:35 am Purchase |
2021-12-31 | 13G | PubMatic, Inc. PUBM |
Schonfeld Strategic Advisors LLC | 517,926 1.880% |
75,726![]() (+17.12%) |
Filing History |
2022-02-14 11:34 am Sale |
2021-12-31 | 13G | CHURCHILL CAP CORP V UNIT 1 CL CCVU |
Schonfeld Strategic Advisors LLC | 16,518 3.300% |
-2,503,482![]() (-99.34%) |
Filing History |
2021-02-16 1:29 pm Purchase |
2020-12-31 | 13G | PubMatic, Inc. PUBM |
Schonfeld Strategic Advisors LLC | 442,200 7.490% |
442,200![]() (New Position) |
Filing History |
2021-02-16 1:28 pm Purchase |
2020-12-31 | 13G | CHURCHILL CAP CORP V UNIT 1 CL CCVU |
Schonfeld Strategic Advisors LLC | 2,520,000 5.040% |
2,520,000![]() (New Position) |
Filing History |
2021-02-16 1:26 pm Sale |
2020-12-31 | 13G | Clearwater Paper Corporation CLW |
Schonfeld Strategic Advisors LLC | 201,189 1.210% |
-633,825![]() (-75.91%) |
Filing History |